Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: A European strategy for developing lung cancer molecular diagnostics in high risk populations

Simple item page
dc.contributor.authorField, JK
dc.contributor.authorBrambilla, C
dc.contributor.authorCaporaso, N
dc.contributor.authorFlahault, A
dc.contributor.authorHenschke, C
dc.contributor.authorHerman, J
dc.contributor.authorHirsch, F
dc.contributor.authorLachmann, P
dc.contributor.authorLam, S
dc.contributor.authorMaier, S
dc.contributor.authorMontuenga, LM
dc.contributor.authorMulshine, J
dc.contributor.authorMurphy, M
dc.contributor.authorPullen, J
dc.contributor.authorSpitz, M
dc.contributor.authorTockman, M
dc.contributor.authorTyndale, R
dc.contributor.authorWistuba, I
dc.contributor.authorYoungson, J
dc.date.accessioned2025-01-21T01:10:44Z
dc.date.available2025-01-21T01:10:44Z
dc.date.issued2002
dc.description.abstractThe Second Molecular Biomarkers Workshop was held at the Roy Castle International Centre for Lung Cancer Research in Liverpool, in June 2001 and it brought together experts in the clinical, epidemiological and molecular-pathology of lung cancer from Europe and the USA, to address issues surrounding the development of a European strategy for early lung cancer detection. The 2001 Workshop Breakout Groups concentrated on the current challenges in the early detection of lung cancer which need to be addressed in the light of the recent surge in interest in many countries for mounting new clinical trials to evaluate the utility of Spiral CT in early lung cancer detection. If population-based trials of CT screening are mounted it will also be a favorable clinical environment in which to evaluate efficiently recent advances in molecular screening and genotyping. The Workshop focused specifically on: a) clinical and molecular biomarkers, b) sputum as an early detection and diagnostic tool, c) validation of molecular markers prior to their use in early detection trials and d) ethical issues that have to be considered in early lung cancer detection trials. A distillation of the Workshop discussions is given in this article.
dc.fuente.origenWOS
dc.identifier.eissn1791-2423
dc.identifier.issn1019-6439
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/96713
dc.identifier.wosidWOS:000176913000019
dc.issue.numero2
dc.language.isoen
dc.pagina.final373
dc.pagina.inicio369
dc.revistaInternational journal of oncology
dc.rightsacceso restringido
dc.subjectlung cancer
dc.subjectconsensus statement
dc.subjectworkshop report
dc.subjectSpiral CT
dc.subjectmolecular biomarkers
dc.subjectsputum
dc.subjectvalidation
dc.subjectethics
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleConsensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: A European strategy for developing lung cancer molecular diagnostics in high risk populations
dc.typeartículo
dc.volumen21
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas